# Suzhou Dima Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suzhou-dima-biotechnology

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Latest round: Angel (Sep 11, 2019)
- Investors on record: 2

## About

Based in Suzhou, China and established in 2019, Suzhou Dima Biotechnology operates as a biotechnology company which focuses on providing antibody of cancer treatment. In September 2019, the company closed an angel funding from new investors Guoqian Venture Capital and Huatai Zijin Investment. Another unspecified investor also participated in this funding.

Suzhou Dima Biotechnology focsues on the research and development of recombinant monoclonal antibodies for tumor immunotherapy products and services. The company independently developed RECmAb digital monoclonal antibody technology, which can obtain monoclonal antibodies.

The company generates revenue by developing tumor immunotherapy and monoclonal antibodies.

## Funding rounds

- Angel, Sep 11, 2019 — Huatai Zijin Investment, Guoqian Venture Capital

## Investors

- Huatai Zijin Investment (https://capitalatlas.ai/funds/huatai-zijin-investment) — Angel
- Guoqian Venture Capital (https://capitalatlas.ai/funds/guoqian-venture-capital) — Angel